All posts by psufka

Stem-Cell Transplantation for Scleroderma

January 19, 2018Uncategorizedpsufka

Our next #RheumJC session will be Thursday, January 25th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).

We’ll be discussing the recent New England Journal of Medicine Article: Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Favorite Abstracts from the 2017 ACR Annual Meeting

November 22, 2017Uncategorizedpsufka

Our next #RheumJC session will be Thursday, November 30th at 10pm Eastern Time (click here to find this in your time zone).

We’ll be discussing four of our favorite abstracts from the recent #ACR17 Meeting in San Diego:

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

October 21, 2017Uncategorizedpsufka

Our next #RheumJC session will be Thursday, October 26th.

We’ll be discussing the article Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis epublished in Arthritis Care & Research

When: 10pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Role of Blocking IL-1 with Canakinumab for Atherosclerotic Disease

September 23, 2017Role of Blocking IL-1 with Canakinumab for Atherosclerotic Diseasepsufka

Update 09/29/2017: Here is a Storify summary of our session: https://storify.com/psufka/rheumjc-from-09-28-2017

Our next #RheumJC session will be Thursday, September 28th.

We’ll be discussing the recently published NEJM article Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Also refer to the associated editorial in NEJM, Targeting Inflammation in Coronary Artery Disease.

When: 10pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Guidelines on Perioperative Management of Antirheumatic Medication for Hip & Knee Arthroplasty

July 22, 2017Journal Club #20: Guidelines on Perioperative Management of Antirheumatic Medication for Hip & Knee Arthroplastypsufka

After a brief summer break, #RheumJC is back!

Our next session will be Thursday, July 27th, discussing the recently published guidelines in Arthritis Care & Research: 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

First session: 4pm Eastern Time (find this in your time zone)
Second session: 10pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Effect of methotrexate discontinuation on efficacy of influenza vaccination in RA

May 21, 2017Journal Club #19: Effect of methotrexate discontinuation on efficacy of influenza vaccination in RApsufka

This week’s #RheumJC will be Thursday, May 25th, discussing the May 2017 Annals of the Rheumatic Diseases article: Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial by Dr. Jin Kyun Park, et al.

First session: 4pm Eastern Time (find this in your time zone)
Second second: 9pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Spinal Manipulation in the Treatment of Low Back Pain

April 21, 2017Journal Club #18: Spinal Manipulation in the Treatment of Low Back Painpsufka

Our next #RheumJC discussion will be Thursday, April 27th, discussing the April 2017 JAMA article: Association of Spinal Manipulative Therapy With Clinical Benefit and Harm for Acute Low Back Pain: Systematic Review and Meta-analysis by Dr. Neil M. Paige, et al.

The publisher has graciously made this article free to access on April 26–27.

We also suggest the accompanying editorial: The Role of Spinal Manipulation in the Treatment of Low Back Pain.

Please note, our second session will be held one hour earlier than our usual time.

First session: 4pm Eastern Time (find this in your time zone)
Second second: 9pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Changes in Ultrasonographic Vascularity with Adalimumab + MTX in RA

March 24, 2017Journal Club #17: Changes in Ultrasonographic Vascularity with Adalimumab + MTX in RApsufka

Our next #RheumJC discussion will be Thursday, March 30th, discussing the recent November 2016 Arthritis & Rheumatology article: Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate) by Dr. Gurjit S. Kaeley, et al. This article is open-access.

As an additional reference, we suggest the Nature Reviews Rheumatology article: Using ultrasonography to facilitate best practice in diagnosis and management of RA.

First session: 4pm Eastern Time (find this in your time zone)
Second second: 10pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

Use of Lesinurad with Allopurinol for Gout

February 16, 2017Journal Club #16: Use of Lesinurad with Allopurinol for Goutpsufka

Our next #RheumJC discussion will be Thursday, February 23rd, discussing the January 2017 Arthritis & Rheumatology article: Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study) by Dr. Kenneth G. Saag, et al. This article is open-access.

First session: 4pm Eastern Time (find this in your time zone)
Second second: 10pm Eastern Time (find this in your time zone)

If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.

We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.

As always:

Please remember to try to stay on topic whenever possible.
Be polite and courteous.
Do not violate HIPAA.

We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.

#RheumJC joining #NephJC to look at the PRECISION Trial

January 18, 2017NephJC Collaborationpsufka

Artwork by Holly Fischer [CC BY 3.0 (http://creativecommons.org/licenses/by/3.0)], via Wikimedia Commons.

For our next journal club activity, we’ll be teaming up with the Nephrology Journal Club #NephJC to discuss the PRECISION Trial, published in NEJM: Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis by Nissen SE, et al. This article is open access via the NephJC blog post.

As many of you may recall, a portion of this data was presented during the #ACR16 late breaking abstract session: 1L: The Cardiovascular Safety of Celecoxib Versus Ibuprofen or Naproxen in 24,081 Patients with Osteoarthritis or Rheumatoid Arthritis.

When:

Session 1: Tuesday, January 24 at 9pm Eastern (find this in your time zone)
Session 2: Wednesday January 25 at 3pm Eastern / 8pm GMT (find this in your time zone)

Additional Details:

For this session, we’ll plan on using the #NephJC hashtag for the discussion, since they’ll be hosting the session.
As usual, we suggest using the website tchat.io in your desktop web browser as the best way to participate in the chat.